CHAPTER 4: PRIME EDITING AND CRISPR MARKET, BY SERVICE
4.1. Overview
4.1.1. Market size and forecast
4.2. Cell line engineering
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Genome Regulation
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Gene editing
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. Gene-modified cell therapy
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country
CHAPTER 5: PRIME EDITING AND CRISPR MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Biomedical research and therapy
5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market analysis, by country
5.3. Agricultural Research
5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market analysis, by country
5.4. Others
5.4.1. Key market trends, growth factors, and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market analysis, by country
CHAPTER 6: PRIME EDITING AND CRISPR MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Academic institutions
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market analysis, by country
6.2.4. Academic institutions, by application
6.3. Biotechnology & pharma companies
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market analysis, by country
6.3.4. Biotechnology & pharma companies, by application
6.4. Contract Research Organizations
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market analysis, by country
6.4.4. Contract research organizations, by application
CHAPTER 7: PRIME EDITING AND CRISPR MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. North America prime editing and CRISPR market, by service
7.2.3. North America prime editing and CRISPR market, by application
7.2.4. North America prime editing and CRISPR market, by end user
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. U.S. prime editing and CRISPR market, by service
7.2.5.1.2. U.S. prime editing and CRISPR market, by application
7.2.5.1.3. U.S. prime editing and CRISPR market, by end user
7.2.5.2. Canada
7.2.5.2.1. Canada prime editing and CRISPR market, by service
7.2.5.2.2. Canada prime editing and CRISPR market, by application
7.2.5.2.3. Canada prime editing and CRISPR market, by end user
7.2.5.3. Mexico
7.2.5.3.1. Mexico prime editing and CRISPR market, by service
7.2.5.3.2. Mexico prime editing and CRISPR market, by application
7.2.5.3.3. Mexico prime editing and CRISPR market, by end user
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Europe prime editing and CRISPR market, by service
7.3.3. Europe prime editing and CRISPR market, by application
7.3.4. Europe prime editing and CRISPR market, by end user
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Germany prime editing and CRISPR market, by service
7.3.5.1.2. Germany prime editing and CRISPR market, by application
7.3.5.1.3. Germany prime editing and CRISPR market, by end user
7.3.5.2. France
7.3.5.2.1. France prime editing and CRISPR market, by service
7.3.5.2.2. France prime editing and CRISPR market, by application
7.3.5.2.3. France prime editing and CRISPR market, by end user
7.3.5.3. UK
7.3.5.3.1. UK prime editing and CRISPR market, by service
7.3.5.3.2. UK prime editing and CRISPR market, by application
7.3.5.3.3. UK prime editing and CRISPR market, by end user
7.3.5.4. Italy
7.3.5.4.1. Italy prime editing and CRISPR market, by service
7.3.5.4.2. Italy prime editing and CRISPR market, by application
7.3.5.4.3. Italy prime editing and CRISPR market, by end user
7.3.5.5. Spain
7.3.5.5.1. Spain prime editing and CRISPR market, by service
7.3.5.5.2. Spain prime editing and CRISPR market, by application
7.3.5.5.3. Spain prime editing and CRISPR market, by end user
7.3.5.6. Rest of Europe
7.3.5.6.1. Rest of Europe prime editing and CRISPR market, by service
7.3.5.6.2. Rest of Europe prime editing and CRISPR market, by application
7.3.5.6.3. Rest of Europe prime editing and CRISPR market, by end user
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Asia-Pacific prime editing and CRISPR market, by service
7.4.3. Asia-Pacific prime editing and CRISPR market, by application
7.4.4. Asia-Pacific prime editing and CRISPR market, by end user
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Japan prime editing and CRISPR market, by service
7.4.5.1.2. Japan prime editing and CRISPR market, by application
7.4.5.1.3. Japan prime editing and CRISPR market, by end user
7.4.5.2. China
7.4.5.2.1. China prime editing and CRISPR market, by service
7.4.5.2.2. China prime editing and CRISPR market, by application
7.4.5.2.3. China prime editing and CRISPR market, by end user
7.4.5.3. Australia
7.4.5.3.1. Australia prime editing and CRISPR market, by service
7.4.5.3.2. Australia prime editing and CRISPR market, by application
7.4.5.3.3. Australia prime editing and CRISPR market, by end user
7.4.5.4. India
7.4.5.4.1. India prime editing and CRISPR market, by service
7.4.5.4.2. India prime editing and CRISPR market, by application
7.4.5.4.3. India prime editing and CRISPR market, by end user
7.4.5.5. South Korea
7.4.5.5.1. South Korea prime editing and CRISPR market, by service
7.4.5.5.2. South Korea prime editing and CRISPR market, by application
7.4.5.5.3. South Korea prime editing and CRISPR market, by end user
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Rest of Asia-Pacific prime editing and CRISPR market, by service
7.4.5.6.2. Rest of Asia-Pacific prime editing and CRISPR market, by application
7.4.5.6.3. Rest of Asia-Pacific prime editing and CRISPR market, by end user
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. LAMEA prime editing and CRISPR market, by service
7.5.3. LAMEA prime editing and CRISPR market, by application
7.5.4. LAMEA prime editing and CRISPR market, by end user
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Brazil prime editing and CRISPR market, by service
7.5.5.1.2. Brazil prime editing and CRISPR market, by application
7.5.5.1.3. Brazil prime editing and CRISPR market, by end user
7.5.5.2. Saudi Arabia
7.5.5.2.1. Saudi Arabia prime editing and CRISPR market, by service
7.5.5.2.2. Saudi Arabia prime editing and CRISPR market, by application
7.5.5.2.3. Saudi Arabia prime editing and CRISPR market, by end user
7.5.5.3. South Africa
7.5.5.3.1. South Africa prime editing and CRISPR market, by service
7.5.5.3.2. South Africa prime editing and CRISPR market, by application
7.5.5.3.3. South Africa prime editing and CRISPR market, by end user
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Rest of LAMEA prime editing and CRISPR market, by service
7.5.5.4.2. Rest of LAMEA prime editing and CRISPR market, by application
7.5.5.4.3. Rest of LAMEA prime editing and CRISPR market, by end user
List of Tables
TABLE 01. PRIME EDITING AND CRISPR MARKET, BY SERVICE, 2020–2030 ($MILLION)
TABLE 02. PRIME EDITING AND CRISPR MARKET FOR CELL LINE ENGINNERING, BY REGION, 2020–2030 ($MILLION)
TABLE 03. PRIME EDITING AND CRISPR MARKET FOR REGULATION OF GENE, BY REGION, 2020–2030 ($MILLION)
TABLE 04. PRIME EDITING AND CRISPR MARKET FOR GENE EDITING, BY REGION, 2020–2030 ($MILLION)
TABLE 05. PRIME EDITING AND CRISPR MARKET FOR GENE MODIFIED CELL THERAPY, BY REGION, 2020–2030 ($MILLION)
TABLE 06. GLOBAL PRIME EDITING AND CRISPR MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 07. PRIME EDITING AND CRISPR MARKET FOR BIOMEDICAL RESEARCH AND THERAPY, BY REGION, 2020–2030 ($MILLION)
TABLE 08. PRIME EDITING AND CRISPR MARKET FOR AGRICULTURAL RESEARCH, BY REGION, 2020–2030 ($MILLION)
TABLE 09. PRIME EDITING AND CRISPR MARKET FOR OTHER RESEARCH, BY REGION, 2020–2030 ($MILLION)
TABLE 10. GLOBAL PRIME EDITING AND CRISPR MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 11. PRIME EDITING AND CRISPR MARKET FOR ACADEMIC INSTITUTIONS, BY REGION, 2020–2030 ($MILLION)
TABLE 12. ACADEMIC INSTITUTIONS, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 13. PRIME EDITING AND CRISPR MARKET FOR BIOTECHNOLOGY & PHARMA COMPANIES, BY REGION, 2020–2030 ($MILLION)
TABLE 14. BIOTECHNOLOGY & PHARMA COMPANIES, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 15. PRIME EDITING AND CRISPR MARKET FOR CONTRACT RESEARCH ORGANIZATION, BY REGION, 2020–2030 ($MILLION)
TABLE 16. CONTRACT RESEARCH ORGANIZATIONS, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 17. PRIME EDITING AND CRISPR MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 18. NORTH AMERICA PRIME EDITING AND CRISPR MARKET, BY SERVICE, 2020–2030 ($MILLION)
TABLE 19. NORTH AMERICA PRIME EDITING AND CRISPR MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 20. NORTH AMERICA PRIME EDITING AND CRISPR MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 21. NORTH AMERICA PRIME EDITING AND CRISPR MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 22. U.S. PRIME EDITING AND CRISPR MARKET, BY SERVICE, 2020–2030 ($MILLION)
TABLE 23. U.S. PRIME EDITING AND CRISPR MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 24. U.S. PRIME EDITING AND CRISPR MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 25. CANADA PRIME EDITING AND CRISPR MARKET, BY SERVICE, 2020–2030 ($MILLION)
TABLE 26. CANADA PRIME EDITING AND CRISPR MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 27. CANADA PRIME EDITING AND CRISPR MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 28. MEXICO PRIME EDITING AND CRISPR MARKET, BY SERVICE, 2020–2030 ($MILLION)
TABLE 29. MEXICO PRIME EDITING AND CRISPR MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 30. MEXICO PRIME EDITING AND CRISPR MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 31. EUROPE PRIME EDITING AND CRISPR MARKET, BY SERVICE, 2020–2030 ($MILLION)
TABLE 32. EUROPE PRIME EDITING AND CRISPR MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 33. EUROPE PRIME EDITING AND CRISPR MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 34. EUROPE PRIME EDITING AND CRISPR MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 35. GERMANY PRIME EDITING AND CRISPR MARKET, BY SERVICE, 2020–2030 ($MILLION)
TABLE 36. GERMANY PRIME EDITING AND CRISPR MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 37. GERMANY PRIME EDITING AND CRISPR MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 38. FRANCE PRIME EDITING AND CRISPR MARKET, BY SERVICE, 2020–2030 ($MILLION)
TABLE 39. FRANCE PRIME EDITING AND CRISPR MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 40. FRANCE PRIME EDITING AND CRISPR MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 41. UK PRIME EDITING AND CRISPR MARKET, BY SERVICE, 2020–2030 ($MILLION)
TABLE 42. UK PRIME EDITING AND CRISPR MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 43. UK PRIME EDITING AND CRISPR MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 44. ITALY PRIME EDITING AND CRISPR MARKET, BY SERVICE, 2020–2030 ($MILLION)
TABLE 45. ITALY PRIME EDITING AND CRISPR MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 46. ITALY PRIME EDITING AND CRISPR MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 47. SPAIN PRIME EDITING AND CRISPR MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 48. SPAIN PRIME EDITING AND CRISPR MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 49. REST OF EUROPE PRIME EDITING AND CRISPR MARKET, BY SERVICE, 2020–2030 ($MILLION)
TABLE 50. REST OF EUROPE PRIME EDITING AND CRISPR MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 51. REST OF EUROPE PRIME EDITING AND CRISPR MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 52. ASIA-PACIFIC PRIME EDITING AND CRISPR MARKET, BY SERVICE, 2020–2030 ($MILLION)
TABLE 53. ASIA-PACIFIC PRIME EDITING AND CRISPR MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 54. ASIA-PACIFIC PRIME EDITING AND CRISPR MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 55. ASIA-PACIFIC PRIME EDITING AND CRISPR MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 56. JAPAN PRIME EDITING AND CRISPR MARKET, BY SERVICE, 2020–2030 ($MILLION)
TABLE 57. JAPAN PRIME EDITING AND CRISPR MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 58. JAPAN PRIME EDITING AND CRISPR MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 59. CHINA PRIME EDITING AND CRISPR MARKET, BY SERVICE, 2020–2030 ($MILLION)
TABLE 60. CHINA PRIME EDITING AND CRISPR MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 61. CHINA PRIME EDITING AND CRISPR MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 62. AUSTRALIA PRIME EDITING AND CRISPR MARKET, BY SERVICE, 2020–2030 ($MILLION)
TABLE 63. AUSTRALIA PRIME EDITING AND CRISPR MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 64. AUSTRALIA PRIME EDITING AND CRISPR MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 65. INDIA PRIME EDITING AND CRISPR MARKET, BY SERVICE, 2020–2030 ($MILLION)
TABLE 66. INDIA PRIME EDITING AND CRISPR MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 67. INDIA PRIME EDITING AND CRISPR MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 68. SOUTH KOREA PRIME EDITING AND CRISPR MARKET, BY SERVICE, 2020–2030 ($MILLION)
TABLE 69. SOUTH KOREA PRIME EDITING AND CRISPR MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 70. SOUTH KOREA PRIME EDITING AND CRISPR MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC PRIME EDITING AND CRISPR MARKET, BY SERVICE, 2020–2030 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC PRIME EDITING AND CRISPR MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 73. REST OF ASIA-PACIFIC PRIME EDITING AND CRISPR MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 74. LAMEA PRIME EDITING AND CRISPR MARKET, BY SERVICE, 2020–2030 ($MILLION)
TABLE 75. LAMEA PRIME EDITING AND CRISPR MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 76. LAMEA PRIME EDITING AND CRISPR MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 77. LAMEA PRIME EDITING AND CRISPR MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 78. BRAZIL PRIME EDITING AND CRISPR MARKET, BY SERVICE, 2020–2030 ($MILLION)
TABLE 79. BRAZIL PRIME EDITING AND CRISPR MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 80. BRAZIL PRIME EDITING AND CRISPR MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 81. SAUDI ARABIA PRIME EDITING AND CRISPR MARKET, BY SERVICE, 2020–2030 ($MILLION)
TABLE 82. SAUDI ARABIA PRIME EDITING AND CRISPR MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 83. SAUDI ARABIA PRIME EDITING AND CRISPR MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 84. SOUTH AFRICA PRIME EDITING AND CRISPR MARKET, BY SERVICE, 2020–2030 ($MILLION)
TABLE 85. SOUTH AFRICA PRIME EDITING AND CRISPR MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 86. SOUTH AFRICA PRIME EDITING AND CRISPR MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 87. REST OF LAMEA PRIME EDITING AND CRISPR MARKET, BY SERVICE, 2020–2030 ($MILLION)
TABLE 88. REST OF LAMEA PRIME EDITING AND CRISPR MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 89. REST OF LAMEA PRIME EDITING AND CRISPR MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 90. BEAM: COMPANY SNAPSHOT
TABLE 91. BEAM: OPERATING SEGMENTS
TABLE 92. BEAM: PRODUCT PORTFOLIO
TABLE 93. CPISPR: COMPANY SNAPSHOT
TABLE 94. CRISPR: OPERATING SEGMENTS
TABLE 95. CRISPR: PRODUCT PORTFOLIO
TABLE 96. GENSCRIPT: COMPANY SNAPSHOT
TABLE 97. GENSCRIPT: OPERATING SEGMENTS
TABLE 98. GENSCRIPT: PRODUCT PORTFOLIO
TABLE 99. HORIZON: COMPANY SNAPSHOT
TABLE 100. HORIZON: OPERATING SEGMENTS
TABLE 101. HORIZON: PRODUCT PORTFOLIO
TABLE 102. IDT: COMPANY SNAPSHOT
TABLE 103. IDT: OPERATING SEGMENTS
TABLE 104. IDT: PRODUCT PORTFOLIO
TABLE 105. INTELLIA: COMPANY SNAPSHOT
TABLE 106. INTELLIA: OPERATING SEGMENTS
TABLE 107. INTELLIA: PRODUCT PORTFOLIO
TABLE 108. INSCRIPTA: COMPANY SNAPSHOT
TABLE 109. INSCRIPTA: OPERATING SEGMENTS
TABLE 110. INSCRIPTA: PRODUCT PORTFOLIO
TABLE 111. PRECISION COMPANY SNAPSHOT
TABLE 112. PRECISION: OPERATING SEGMENTS
TABLE 113. PRECISION: PRODUCT PORTFOLIO
TABLE 114. SANGAMO: COMPANY SNAPSHOT
TABLE 115. SANGAMO: OPERATING SEGMENTS
TABLE 116. SANGAMO: PRODUCT PORTFOLIO
TABLE 117. SYNTHEGO: COMPANY SNAPSHOT
TABLE 118. SYNTHEGO: OPERATING SEGMENTS
TABLE 119. SYNTHEGO: PRODUCT PORTFOLIO
List of Figures
FIGURE 01. PRIME EDITING AND CRISPR MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2018–2021
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2018–2021
FIGURE 06. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07. MODERATE BARGAINING POWER OF BUYERS
FIGURE 08. MODERATE THREAT OF SUBSTITUTES
FIGURE 09. HIGH THREAT OF NEW ENTRANTS
FIGURE 10. MODERATE INTENSITY OF RIVALRY
FIGURE 11. TOP PLAYER POSITIONING, 2020
FIGURE 12. IMPACT ANALYSIS
FIGURE 13. COMPARATIVE ANALYSIS OF PRIME EDITING AND CRISPR MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2020–2030 (%)
FIGURE 14. COMPARATIVE ANALYSIS OF PRIME EDITING AND CRISPR MARKET FOR REGULATION OF GENOME, BY COUNTRY, 2020–2030 (%)
FIGURE 15. COMPARATIVE ANALYSIS OF PRIME EDITING AND CRISPR MARKET FOR GENE EDITING, BY COUNTRY, 2020–2030 (%)
FIGURE 16. COMPARATIVE ANALYSIS OF PRIME EDITING AND CRISPR MARKET FOR GENE MODIFIED CELL THERAPY, BY COUNTRY, 2020–2030 (%)
FIGURE 17. COMPARATIVE ANALYSIS OF PRIME EDITING AND CRISPR MARKET FOR BIOMEDICAL RESEARCH AND THERAPY, BY COUNTRY, 2020–2030 (%)
FIGURE 18. COMPARATIVE ANALYSIS OF PRIME EDITING AND CRISPR MARKET FOR AGRICULTURAL RESEARCH, BY COUNTRY, 2020–2030 (%)
FIGURE 19. COMPARATIVE ANALYSIS OF PRIME EDITING AND CRISPR MARKET FOR OTHER RESEARCH, BY COUNTRY, 2020–2030 (%)
FIGURE 20. COMPARATIVE ANALYSIS OF PRIME EDITING AND CRISPR MARKET FOR ACADEMIC INSTITUTIONS, BY COUNTRY, 2020–2030 (%)
FIGURE 21. COMPARATIVE ANALYSIS OF PRIME EDITING AND CRISPR MARKET FOR BIOTECHNOLOGY & PHARMA COMPANIES, BY COUNTRY, 2020–2030 (%)
FIGURE 22. COMPARATIVE ANALYSIS OF PRIME EDITING AND CRISPR MARKET FOR CONTRACT RESEARCH ORGANIZATION, BY COUNTRY, 2020–2030 (%)
FIGURE 23. GENSCRIPT: NET SALES, 2018-2020 ($MILLION)
FIGURE 24. GENSCRIPT: REVENU.S.ARE BY SEGMENT, 2020 (%)
FIGURE 25. GENSCRIPT: REVENU.S.ARE BY REGION, 2020 (%)
FIGURE 26. HORIZON: NET SALES, 2017-2019 ($MILLION)
FIGURE 27. HORIZON: REVENU.S.ARE BY SEGMENT, 2019 (%)
FIGURE 28. HORIZON: REVENU.S.ARE BY REGION 2019 (%)
FIGURE 29. PRECISION: NET SALES, 2018-2020 ($MILLION)
FIGURE 30. PRECISION: REVENU.S.ARE BY SEGMENT, 2020 (%)
FIGURE 31. SANGAMO: NET SALES, 2018–2020 ($MILLION)